Patterns of response to intravenous enoximone.
The cases of four male patients with severe cardiac failure due to ischaemic heart disease are presented. They were selected on the basis of their wide variation in response to the intravenous administration of enoximone, an haemodynamic stimulant licensed recently. They serve to emphasize the need for close haemodynamic and electrocardiographic monitoring in a unit with appropriate facilities for remedial action if adverse responses occur when this drug is employed.